PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
SMi Group

Press Release


Receive press releases from SMi Group: By Email RSS Feeds:

Meet Respiratory Experts from Novartis, Chiesi, MedImmune and Mylan at COPD 2016


SMi Reports (2016.06.24, London, UK): The 8th annual COPD conference will be returning to London on 19 – 20 October 2016. Experts from Novartis, Chiesi, MedImmune, and Mylan will speak at this event.

London, United Kingdom, June 29, 2016 --(PR.com)-- Earlier this year Novartis announced a collaboration with Qualcomm Incorporated through its subsidiary, Qualcomm Life, Inc., in digital innovation with the Breezhaler(TM) inhaler device to treat COPD. The Breezhaler(TM) inhaler device will enable patients to have access to their own data on the use of their inhaler in near real time. (Source: COPD News Today)

SMi Group is delighted to announce Dr. Frank Thielmann, Lead Inhalation New Solids, Novartis Pharma AG will be presenting at the 8th annual COPD conference on: "Advances in device and formulation technologies for pulmonary drug delivery."

Presentation topics will include state of the art formulation strategy and technologies, relevant physicochemical properties and how to measure them, device formulation interaction, and trends in device development.

Key speakers for 2016 include expert leaders from Mylan, Inc., Chiesi Pharmaceuticals, MedImmune, Janssen Pharmaceutical Companies of Johnson & Johnson, Amgen, Glenmark Pharmaceuticals, Actavis, AstraZeneca, my Mhealth Limited, University of Melbourne, University of Southampton, Imperial College London, and many more.

For further information on COPD 2016, visit www.copd-conference.co.uk
The event programme topics will include:
· Predicting drug efficacy using integrative models for chronic respiratory diseases
· New approaches for COPD drug development: An opportunity for disease interception
· Advances in device and formulation technologies for pulmonary drug delivery

Attendees are advised to register before 30th June to save £400.

For media enquiries please contact Anna Serazetdinova on +44 20 7827 6180 or aserazetdinova@smi-online.co.uk

For delegate enquiries contact Matthew Apps +44 (0) 20 7827 6093 or email mapps@smi-online.co.uk

For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk

8th annual COPD Conference and Exhibition
19th – 20th October 2016
Holiday Inn Kensington Forum, London, UK
Contact e-mail: aserazetdinova@smi-online.co.uk
Contact number: +44 (0) 20 7827 6093
Event Website: www.copd-conference.co.uk

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact Information
SMi Group
Anna Serazetdinova
+44 20 7827 6093
Contact
www.copd-conference.co.uk/prcom

Click here to view the list of recent Press Releases from SMi Group
Promote Your Business